- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02631083
The Influence of Glucose Flux on Fat Synthesis in a Whole Body Calorimeter
August 1, 2017 updated by: JeyaKumar Henry, Clinical Nutrition Research Centre, Singapore
The Impact of a Low Glycaemic Index (GI) Diet on Daily Blood Glucose Profiles and Energy Flux in Male Chinese Adults.
The study is carried out to find out the inclusion of high and low glycaemic index foods to daily meals and how they impact 24 hour blood glucose fluctuations and energy regulation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The GI is a method of classifying foods based on the food's ability to raise the blood glucose level.
Low GI foods are recommended as they have a lower impact on blood glucose concentrations.
The research sets out to determine the effect of GI on 24 hour blood glucose profiles and energy regulation in Asians.
Healthy, normal-weight, Chinese males will be recruited.
There will be two sessions (consisting of four days for each session) where they will consume either a high or low GI breakfast, lunch, snack (in the whole body calorimeter), and a high or low glycaemic index dinner at home.
They will take part in two test sessions (each spanning over 3 days) with at least five days in between the two sessions.
Their glycaemic response will be measured using a Continuous Glucose Monitoring System (CGMS) throughout the period, while substrate oxidation will be measured over 10 hours in the calorimeter (from breakfast, lunch and snack).
This study specifically attempts to see how having high and low GI meals impact on blood glucose levels and energy regulation in Asians.
The study is important in that it will be the first of its kind in the whole body calorimeter and enable us to compute the rate of fat synthesis and how it is modulated when subjects are fed a high GI diet (increased glucose excursions) and a low GI diet ( blunted glucose) over 24 hours in healthy Asians.
Obesity and diabetes rates are increasing exponentially in Asian populations and Singapore is no exception.
Devising ways and means to staunch the escalation is therefore a priority.
The findings of the research will contribute towards the long-term objectives of developing Asian specific dietary guidelines for weight and glycaemic control.
The study data will also be important for the provision of practical food-based advocacy for better weight and glycaemic control in Singaporeans.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Chinese, male
- Age between 21-40 years
- Body mass index between 17 to 25 kg/m2
- Normal blood pressure (<140/80 Hgmm)
- Fasting blood glucose < 6 mmol/L
Exclusion Criteria:
- Having any metabolic diseases (such as diabetes, hypertension etc)
- On prescription medication
- Having glucose 6-phosphate dehydrogenase deficiency (G6PD)
- Partaking in sports at the competitive and/or endurance levels
- Allergic/intolerant to any of the test foods
- Intentionally restricting food intake
- Smoking
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Breakfast, lunch, snack and dinner (high GI)
Subjects will consume meals which are high glycemic index for breakfast (Honey stars cereal), lunch (glutinous rice meal) and snack (white bread and jam) in the whole body calorimeter.
A take-away high glycemic index dinner will be provided.
|
These meals (cereal, rice and bread meals) will be tested in subjects for their glycaemic response (CGMS) and substrate utilization (calorimeter)
|
|
Experimental: Breakfast, lunch, snack and dinner (low GI)
Subjects will consume meals which are low glycemic index for breakfast (All bran cereal), lunch (basmati rice meal) and snack (multigrain bread and sugar-free jam) in the whole body calorimeter.
A take-away low glycemic index dinner will be provided.
|
These meals (cereal, rice and bread meals) will be tested in subjects for their glycaemic response (CGMS) and substrate utilization (calorimeter)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Daily blood glucose profile
Time Frame: 24 hours
|
The daily total blood glucose response is measured for each low and high GI treatment as the area under the curve over 24 hours using CGMS for breakfast, lunch, snack and dinner.
|
24 hours
|
|
Glycaemic response The blood glucose response to low and high GI test foods measured 2 hours post consumption using the Continuous Glucose Monitoring System (CGMS)
Time Frame: 2 hours post consumption
|
The blood glucose response to low and high GI test foods measured 2 hours post consumption using the Continuous Glucose Monitoring System (CGMS) The blood glucose response to low and high GI test foods measured 2 hours post consumption using the Continuous Glucose Monitoring System (CGMS) |
2 hours post consumption
|
|
Substrate oxidation
Time Frame: 2 hours post consumption
|
The carbohydrate and fat oxidation (i.e Respiratory Quotient) after consumption of low and high GI test foods measured 2 hours post consumption using indirect calorimetry in a whole body calorimeter.
This is done over 10 hours in the whole body calorimeter measured for breakfast, lunch and snack only
|
2 hours post consumption
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 14, 2014
Primary Completion (Actual)
July 31, 2017
Study Completion (Actual)
July 31, 2017
Study Registration Dates
First Submitted
December 11, 2015
First Submitted That Met QC Criteria
December 11, 2015
First Posted (Estimate)
December 15, 2015
Study Record Updates
Last Update Posted (Actual)
August 2, 2017
Last Update Submitted That Met QC Criteria
August 1, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014/00960
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No plan to share data
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes, Obesity, Prediabetes
-
May Faraj, PDt, PhDDiabetes CanadaNot yet recruitingType 2 Diabetes | Obesity & Overweight | Prediabetes / Type 2 Diabetes | Obesity and Diabetes Mellitus, Type 2 | Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)Canada
-
The University of Hong KongNot yet recruitingObesity | PreDiabetes | Type 2 DiabetesHong Kong
-
Ministry of Health, MalaysiaUniversiti Putra MalaysiaRecruitingPreDiabetes | Diabete Type 2 | Obesity; EndocrineMalaysia
-
Clinica Universidad de Navarra, Universidad de...Ministry of Science and Innovation, Spain; CIBER de Fisiopatología de la Obesidad... and other collaboratorsCompletedInsulin Resistance | Prediabetes / Type 2 Diabetes | Obesity and OverweightSpain
-
Universidad de ZaragozaHospital Miguel ServetCompletedPreDiabetes | Type 2 Diabetes | Overweight or ObesitySpain
-
Maastricht University Medical CenterRecruitingObesity | PreDiabetes | Type 2 DiabetesNetherlands
-
University of MinnesotaCompletedObesity | Overweight | Type 2 Diabetes Mellitus | PreDiabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus in Obese | Overweight and ObesityUnited States
-
Imperial College LondonLondon North West Healthcare NHS TrustCompletedType 2 DiabetesUnited Kingdom
-
University of ZurichUnknownPrediabetes / Type 2 DiabetesSwitzerland
-
Clinical Nutrition Research Centre, SingaporeCompletedObesity | PreDiabetes | Type 2 DiabetesSingapore
Clinical Trials on Breakfast, lunch, snack and dinner
-
The Miriam HospitalBrown University; National Institute of General Medical Sciences (NIGMS)UnknownSleep | Weight Loss | Adolescent Obesity | DietUnited States
-
Fudan UniversityActive, not recruiting
-
Riphah International UniversityRecruiting
-
Westlake UniversityHangzhou Maternal and Child Health HospitalActive, not recruitingDiabetes, Gestational | Pregnancy in Diabetics | Intrauterine HyperglycemiaChina
-
Westlake UniversityWenzhou People's HospitalRecruitingGestational Diabetes Mellitus | Nutrition, Healthy | Intrauterine Hyperglycemia | Birth Outcome, AdverseChina
-
University of GlasgowCompletedDiet | Feeding Behavior | Gastrointestinal Microbiome | Meal TimeUnited Kingdom
-
Pennington Biomedical Research CenterCompleted
-
NestléClinical Nutrition Research Centre, SingaporeCompleted
-
University of HohenheimCompleted
-
University of AberdeenMaastricht University; University of SurreyCompleted